Se prevé que el mercado de detección de alto rendimiento alcance los 28.255,71 millones de dólares en 2028, frente a los 15.997,47 millones de dólares en 2021. Se estima que el mercado crecerá con una tasa compuesta anual del 8,5 % de 2021 a 2028.
La detección de alto rendimiento (HTS) es un método de descubrimiento de fármacos que permite realizar pruebas automatizadas de varios compuestos químicos o biológicos para un objetivo biológico específico. Los métodos de detección de alto rendimiento se utilizan ampliamente en la industria farmacéutica, aprovechando la robótica y la automatización para probar rápidamente la actividad biológica o bioquímica de una cantidad significativa de moléculas, generalmente medicamentos. Aceleran el análisis de objetivos, ya que pronto podrán examinarse de forma rentable bibliotecas de compuestos a gran escala. HTS es una herramienta valiosa para evaluar objetivos farmacológicos, agonistas y antagonistas de perfiles farmacológicos para receptores (como GPCR) y enzimas. Factores como un aumento de la inversión en investigación y desarrollo. Se espera que el desarrollo de la industria farmacéutica y biotecnológica y la introducción de productos tecnológicamente avanzados en el mercado de detección de alto rendimiento impulsen el crecimiento del mercado a lo largo de los años. Sin embargo, es probable que el alto costo de la detección de alto rendimiento, la falta de profesionales capacitados y la complejidad en el desarrollo de ensayos obstaculicen el crecimiento del mercado en los próximos años.
Lucrativo Regiones para el mercado de detección de alto rendimiento
Perspectivas del mercado
Aumento de la inversión en investigación y desarrollo por parte de empresas farmacéuticas y Industria de la biotecnología
Un aumento en los gastos de I+D por parte de las empresas farmacéuticas y biotecnológicas y importantes proyectos de medicamentos para tratar diversas enfermedades crónicas como trastornos cardiovasculares, cáncer, trastornos inmunológicos, trastornos metabólicos y trastornos neurológicos son impulsores notables de el mercado de detección de alto rendimiento. Varias empresas farmacéuticas, grandes y pequeñas, participan en el desarrollo y fabricación de nuevas moléculas para varias enfermedades potencialmente mortales. Esto ha llevado a la elección de métodos automatizados de detección de alto rendimiento (HTS) para detectar enormes bibliotecas químicas y satisfacer las necesidades de moléculas diana de fármacos en constante aumento. Por ejemplo, un sistema de detección automatizado de alto rendimiento puede detectar entre 10.000 y 100.000 compuestos objetivo en un solo día. Las empresas farmacéuticas y biotecnológicas han invertido sustancialmente en técnicas de detección de alto rendimiento en la última década. Por ejemplo, la famosa alianza de Millennium Pharmaceuticals, Inc. y Bayer AG ha descubierto con éxito 18 nuevos objetivos farmacológicos y ha sometido cuatro de ellos a pruebas de detección de alto rendimiento en poco menos de ocho meses. La alianza adopta un enfoque de producción novedoso basado en la investigación genómica para llevar las moléculas a ensayos clínicos lo más rápido posible. La detección de alto rendimiento se ha considerado una tecnología vital en el proceso de descubrimiento de fármacos. Por ejemplo, más del 60% de los programas de optimización de la estructura de clientes potenciales completamente desarrollados de Boehringer Ingelheim se deben a la implementación exitosa de HTS. Sólo en EE.UU. se gastan anualmente más de 2.500 millones de dólares estadounidenses en productos y servicios HTS. Las grandes empresas farmacéuticas invierten hasta 35 millones de dólares al año en tecnologías de detección. Una proporción significativa de estas inversiones se destina al desarrollo de nuevos ensayos.
Un número creciente de objetivos farmacológicos para la detección, que se utiliza para el descubrimiento y desarrollo de fármacos, y crecientes inversiones por parte del gobierno. y los institutos de investigación impulsarán aún más la adopción de técnicas HTS. Por ejemplo, en diciembre de 2020, Sygnature Discovery, una organización independiente integrada de descubrimiento de fármacos e investigación por contrato preclínica con sede en el Reino Unido, invirtió alrededor de 4,12 millones de dólares estadounidenses para fortalecer su servicio de detección de alto rendimiento (HTS) y oncología traslacional. Además, programas como "Toxicología en el siglo XXI", una empresa conjunta de la FDA de EE. UU., la Agencia de Protección Ambiental y el Instituto Nacional de Salud de EE. UU., utilizan HTS automatizados para probar productos químicos, formulaciones y medicamentos ambientales, para una amplia gama toxicológica. examen y desarrollar vías específicas asociadas a la enfermedad para predecir los niveles toxicológicos. Estas empresas respaldarán la proliferación del mercado de detección de alto rendimiento.
Información basada en productos y servicios
Basado en productos y servicios, el mercado de detección de alto rendimiento se clasifica en consumibles, instrumentos, accesorios y software. , y servicios. En 2021, el segmento de consumibles tuvo la mayor participación del mercado y se espera que sea testigo de la CAGR más rápida durante el período de pronóstico.
Mercado global de detección de alto rendimiento, por producto y servicio: informe 2021 y 2028
Informe Cobertura
Información basada en tecnología
Basado en la tecnología, el mercado de detección de alto rendimiento se segmenta en ensayos basados en células, laboratorio en -chip, detección de rendimiento ultraalto, bioinformática y tecnología sin etiquetas. En 2021, el segmento de ensayos basados en células tuvo la mayor participación del mercado, mientras que se espera que el segmento de laboratorio en un chip crezca a la CAGR más rápida durante el período de pronóstico.
< /p>
Información basada en aplicaciones
Basado en la aplicación, el mercado de detección de alto rendimiento se segmenta en descubrimiento de fármacos, detección bioquímica, investigación en ciencias biológicas y otras aplicaciones. En 2021, el segmento de descubrimiento de fármacos tuvo la mayor participación del mercado y se espera que crezca al CAGR más rápido durante el período de pronóstico.
Información basada en el usuario final
Según el usuario final, el mercado de detección de alto rendimiento se segmenta en empresas farmacéuticas y de biotecnología, institutos académicos y gubernamentales, organizaciones de investigación por contrato (CRO) y otros. En 2021, el segmento de empresas farmacéuticas y de biotecnología tuvo la mayor participación del mercado, mientras que se espera que el segmento de organizaciones de investigación por contrato (CRO) crezca a la CAGR más rápida durante el período de pronóstico.
Información estratégica
Varias empresas que operan en el mercado de detección de alto rendimiento están adoptando estrategias como lanzamientos de productos, fusiones y adquisiciones, colaboraciones, innovaciones de productos y ampliaciones de carteras de productos para expandir su presencia en todo el mundo. mantener la marca y satisfacer la creciente demanda de los usuarios finales.
Mercado de detección de alto rendimiento: ndash; por producto y servicio
- Consumibles
- Reactivos y kits de ensayo
- Equipo de laboratorio
- Instrumentos
- Sistemas de manipulación de líquidos
- Sistemas de detección
- Accesorios
- Software
- Servicios
Mercado de detección de alto rendimiento: por tecnología
- Ensayos basados en células
- Lab-On-A-Chip
- Detección de rendimiento ultraalto
- Bioinformática
- Tecnología sin etiquetas
- Resonancia de plasmón superficial
- Interferometría reflexiva
- Calorimetría de titulación isotérmica
- Calorimetría diferencial de barrido
- Microvoladizos
- Nanotubos de carbono
- Cristales fotónicos
- Otros
Mercado de detección de alto rendimiento: por aplicación
- Descubrimiento de fármacos
- Detección bioquímica
- Investigación en ciencias biológicas
- Otras aplicaciones
Mercado de detección de alto rendimiento: por usuario final
- Empresas farmacéuticas y de biotecnología
- Institutos académicos y gubernamentales
- Organizaciones de investigación por contrato (CRO)
- Otros< /li>
Mercado de detección de alto rendimiento: por Geografía
- América del Norte
- Estados Unidos
- Canadá
- México
< li>Europa - Francia
- Alemania
- Italia
- Reino Unido
- España
- Resto de Europa
- Asia Pacífico (APAC)
- China
- India
- Corea del Sur
- Japón
- Australia
- Resto de Asia Pacífico
- Medio Oriente y Asia África (MEA)
- Sudáfrica
- Arabia Saudita
- EAU
- Resto de Medio Oriente y África África
- América del Sur (SAM)
- Brasil
- Argentina
- Resto de América del Sur y Central< /li>
Perfiles de empresas
- Agilent Technologies, Inc.
- Axxam SPA
- Eurofins Scientific
- Corning Incorporated
- Molecular Devices, LLC.
- Hamilton Company
- Grupo Merck
- Perkinelmer , Inc.
- Grupo Tecan
- Thermo Fisher Scientific Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Global high-throughput screening market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for high-throughput screening. The US is estimated to hold the largest share in the high-throughput screening market during the forecast period. The growth of the market can be because of prevalence of various diseases, government support for biotechnology and increasing efforts in R&D activities as well as other activities undertaken by the market players operating in the market. In addition, technologically advanced products are likely to stimulate the growth of high-throughput screening market in North America. On the other hand, large pool of population suffering with chronic diseases, rapidly developing healthcare infrastructure, and intellectual capabilities of scientists and researchers in the Asia Pacific is expected to account for the fastest growth of the region during the coming years.
The high-throughput screening market majorly consists of the players such Agilent Technologies, Inc., Axxam S.P.A., Eurofins Scientific, Corning Incorporated, Molecular Devices, LLC., Hamilton Company, Merck Group, Perkinelmer, Inc., Tecan Group and Thermo Fisher Scientific Inc. among others.
The consumables segment dominated the global high-throughput screening market and held the largest revenue share of 44.85% in 2021.
The pharmaceutical and biotechnology companies segment dominated the global high-throughput screening market and accounted for the largest revenue share of 45.27% in 2021.
High-throughput screening (HTS) is a drug discovery process that allows automated testing of large numbers of chemical and/or biological compounds for a specific biological target. High-throughput screening methods are extensively used in the pharmaceutical industry, leveraging robotics and automation to quickly test the biological or biochemical activity of a large number of molecules, usually drugs. They accelerate target analysis, as large-scale compound libraries can quickly be screened in a cost-effective way. HTS is a useful tool for assessing for instance pharmacological targets, pharmacologically profiling agonists and antagonists for receptors (such as GPCRs) and enzymes.
Key factors that are driving the growth of this market increase in investment in research and development by the pharmaceutical and biotechnology industry and the introduction of technologically advanced products in the high throughput screening.
The List of Companies - High Throughput Screening Market
- Agilent Technologies, Inc.
- Axxam S.P.A.
- Eurofins Scientific
- Corning Incorporated
- Molecular Devices, LLC.
- Hamilton Company
- Merck Group
- Perkinelmer, Inc.
- Tecan Group
- Thermo Fisher Scientific Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Sep 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Sep 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Sep 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Sep 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)